Xenetic Biosciences, Inc.XBIONASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank38
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P38
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | -5.91% |
| 2023 | -26.75% |
| 2022 | 50.81% |
| 2021 | 82.71% |
| 2020 | -64.59% |
| 2019 | 69.54% |
| 2018 | -28.97% |
| 2017 | -90.72% |
| 2016 | 1173.66% |
| 2015 | -45.70% |